Patent · US Active

Fc variants with altered binding to FcRn

US8802820B2 · kind B2 · utility

68Cited by
99References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 31, 2007
Grant dateAug 12, 2014
Priority date
Expiry dateAug 2, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/90
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application relates to optimized IgG immunoglobulin variants, engineering methods for their generation, and their application, particularly for therapeutic purposes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.